Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Grunenthal (Branded Product Portfolio)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

14 own and licensed brands in Eastern Europe and the Middle East. The products include Tramal, Zaldiar, Transtec and Palexia currently sold in the contract area in Russia, Bosnia, Latvia, Estonia, Saudi Arabia, Kuwait, Lebanon, Jordan, the United Arab Emirates, Egypt, Yemen, Oman, Bahrain and Qatar.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Zieglerstra├če 6
  • 52078 Aachen
  • Germany

Grunenthal (Branded Product Portfolio) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Grunenthal (Branded Product Portfolio)‘s full profile, request access.

Request full access to PitchBook

Grunenthal (Branded Product Portfolio) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Grunenthal (Branded Product Portfolio)‘s full profile, request access.

Request full access to PitchBook